Robin M Murray Selected Research

Indicators and Reagents (Reagents)

1/2019	IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.
3/2014	Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study.
12/2011	Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study.
4/2008	Selective attention deficits reflect increased genetic vulnerability to schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin M Murray Research Topics

Disease

133	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 12/2004
76	Schizophrenia (Dementia Praecox) 01/2024 - 07/2002
10	Substance-Related Disorders (Drug Abuse) 01/2022 - 08/2004
9	Mental Disorders (Mental Disorder) 06/2023 - 07/2005
7	Cognitive Dysfunction 01/2024 - 01/2013
7	Bipolar Disorder (Manic Depressive Psychosis) 01/2023 - 10/2010
5	Genetic Risk Score 01/2024 - 01/2021
5	Paranoid Disorders (Paranoia) 01/2018 - 01/2013
4	Psychotic Affective Disorders 01/2022 - 01/2009
3	Treatment-Resistant Schizophrenia 01/2021 - 11/2012
2	Neurodevelopmental Disorders 01/2022 - 01/2021
2	Anhedonia 11/2021 - 02/2018
2	Hypersensitivity (Allergy) 01/2021 - 09/2014
2	Mania (Manias) 01/2020 - 12/2004
2	Inflammation (Inflammations) 01/2019 - 12/2011
2	Mood Disorders (Mood Disorder) 01/2018 - 03/2006
2	Asphyxia (Suffocation) 01/2017 - 07/2002
2	Hallucinations (Hallucination) 05/2014 - 08/2010
1	Nausea 01/2023
1	Epilepsy (Aura) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Sleepiness 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Pain (Aches) 01/2023
1	Chronic Pain 01/2023
1	Multiple Sclerosis 01/2023
1	Neoplasms (Cancer) 01/2023
1	Dehydration (Water Stress) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Tardive Dyskinesia 01/2021
1	Infections 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Obesity 12/2019
1	Tobacco Use Disorder (Nicotine Dependence) 06/2019
1	Disease Progression 01/2019
1	Glioma (Gliomas) 01/2018
1	Brain Injuries (Brain Injury) 11/2017

Drug/Important Bio-Agent (IBA)

64	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 09/2007
37	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 04/2005
23	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
8	Dronabinol (THC)FDA LinkGeneric 01/2020 - 08/2010
7	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2022 - 02/2010
6	insulin receptor-related receptor (IRR)IBA 01/2023 - 03/2006
6	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 02/2004
5	Glutamic Acid (Glutamate)FDA Link 01/2024 - 03/2014
5	ProlactinIBA 11/2017 - 06/2005
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2014 - 04/2005
4	CannabidiolIBA 01/2023 - 10/2016
4	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 02/2004
4	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2008
4	AmphetaminesIBA 10/2013 - 05/2009
3	Vitamin D FDA LinkGeneric 01/2024 - 11/2013
3	CannabinoidsIBA 01/2023 - 10/2016
3	EndocannabinoidsIBA 12/2022 - 08/2010
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2011
3	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022 - 01/2014
3	Cocaine (Cocaine HCl)IBA 01/2018 - 03/2006
3	Dihydroxyphenylalanine (Dopa)IBA 11/2017 - 12/2011
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2009 - 10/2006
3	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2005 - 08/2004
2	Medical MarijuanaIBA 12/2023 - 10/2023
2	Dihydrotachysterol (AT 10)IBA 10/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Nicotine FDA Link 06/2019 - 07/2013
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2018 - 10/2017
2	AntibodiesIBA 01/2018 - 10/2017
2	Dopamine Receptors (Dopamine Receptor)IBA 09/2015 - 12/2004
2	N 30IBA 09/2015 - 01/2008
2	Illicit Drugs (Recreational Drugs)IBA 03/2015 - 05/2011
2	Protons (Proton)IBA 11/2014 - 12/2007
2	Lysergic Acid Diethylamide (LSD)IBA 10/2013 - 01/2011
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2009 - 03/2006
2	3' Untranslated Regions (3' UTR)IBA 11/2009 - 08/2009
2	Proline Oxidase (Proline Dehydrogenase)IBA 09/2007 - 08/2004
1	25-hydroxyvitamin DIBA 01/2024
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 06/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Unithiol (DMPS)IBA 01/2021
1	Complement C4 (Complement Component 4)IBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	hydroxide ionIBA 01/2019
1	LipidsIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2018
1	Immunoglobulin G (IgG)IBA 02/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	imidazole mustard (BIC)IBA 01/2018

Therapy/Procedure

3	Length of Stay 12/2023 - 01/2020
3	Therapeutics 10/2013 - 12/2006
2	Cesarean Section (Caesarean Section) 01/2017 - 07/2002
1	Continuity of Patient Care 07/2021
1	Secondary Prevention 01/2021
1	Treatment Delay 01/2020